David Esposito

David Esposito is President and CEO of ONL Therapeutics, a clinical-stage biopharmaceutical company committed to protecting and improving the vision of patients with a range of retinal disease and conditions. As an experienced healthcare executive, David has built and scaled multiple companies that resulted in successful exits to strategic buyers.